European Union Drugs Agency (EUDA)

The European Union Drugs Agency (EUDA) is the leading authority on illicit drugs in Europe. Based in Lisbon, Portugal, the EUDA provides independent scientific evidence and analysis on all aspects of this constantly changing threat to individual lives and wider society. The EUDA contributes to EU and national policies to protect Europe's citizens from drug-related harms. It is an agency of the European Union.

Mission

Our new mission focuses on contributing to European Union (EU) preparedness on drugs through four main actions: anticipate, alert, respond, and learn.

Ketamine in Europe

Event Date
 - 
Online

ObjectiveThis webinar aims to provide insights into the European ketamine market and will expand on health-related harms caused by non-medical ketamine use.

AddictionsCEE 2026

Event Date
 - 
Prague
Czechia

International conference gathering scientists, professionals, policymakers, and other stakeholders from Central and Eastern Europe interested in different aspects of addiction, mental health and its treatment.

18 Jun 2026, 09:00 – 17:30 CEST

Kaiserstein Palace

Launch event: European Drug Report 2026

Event Date
 - 
Online

Join us for the launch of the European Drug Report 2026: Trends and Developments on 9 June 2026. The report delivers the latest evidence on the state of the drugs problem in Europe.

Time: 09:00 WEST (Lisbon), 10:00 CEST (Brussels) (NB time to be confirmed)

EUDA webinar: International drug checking day

Event Date
 - 
Online

Objective: Taking place on the eve of International Drug Checking Day, this webinar offers a timely opportunity to highlight the role drug-checking services play across three domains: harm reduction, drug market monitoring and public health alerts. The session will demonstrate the benefits of drug checking for a variety of stakeholders, including consumers, public health authorities and monitoring bodies.   

Care without conditions — housing-first and employment-first approaches

Event Date
 - 
Online

Background: Across Europe, people who use drugs face persistent barriers to housing, decent work, healthcare and safety. All too often, ‘reintegration’ tends to be tied largely to abstinence, at the risk of excluding those who are not ready, or do not wish, to stop using psychoactive substances.

Novel approaches to prevent the recruitment and participation of young people in European drug markets

Event Date
 - 
Online

Objective: This webinar aims to explore innovative and evidence-informed approaches to preventing the recruitment and involvement of young people in drug markets across Europe. Drawing on interventions implemented in various European countries, the session will examine how these strategies can disrupt pathways into drug-related criminality and offer meaningful alternatives for at-risk young people.

European Drugs Summer School 2026

Event Date
 - 
Lisbon
Portugal

Held in Lisbon, this face-to-face two-week course places special focus on 'A whole-of-society approach to drugs', examining how communities, professionals, policymakers and people who use substances and their families can move from awareness to effective action.

ESPAD Report 2024

Report
 - 
The ESPAD report presents the results of the eighth data-collection wave, which took place in 2024, and marks an impressive 30 years of data collection by this long-standing collaboration. More than 113 000 15- to 16-year-old students from...

Tech-based health and social responses to drug problems

Event Date
 - 
Online

Objective: This webinar will explore how digital innovations are enhancing health and social support for people who use drugs. Participants will gain insights into how technology can bridge gaps in access, provide timely interventions and support vulnerable populations.